These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 3312603

  • 1. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA, Mellinger S, Kohler J, Dorsey JK, Furst DE.
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [Abstract] [Full Text] [Related]

  • 2. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A, Amor B, Menkès CJ.
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [Abstract] [Full Text] [Related]

  • 3. Nicardipine in the treatment of Raynaud's phenomenon: a randomized double-blind trial.
    Kahan A, Amor B, Menkès CJ, Weber S, Guérin F, Degeorges M.
    Angiology; 1987 Apr; 38(4):333-7. PubMed ID: 3555175
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A, Weber S, Amor B, Menkes CJ, Hodara M, Degeorges M.
    Int Angiol; 1985 Apr; 4(2):221-3. PubMed ID: 3831143
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP.
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [Abstract] [Full Text] [Related]

  • 8. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A, McCans J, Willan AR, Ford PM.
    J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
    [Abstract] [Full Text] [Related]

  • 9. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R, Shariat K, von Wilmowsky H, Böhm M.
    Circulation; 2005 Nov 08; 112(19):2980-5. PubMed ID: 16275885
    [Abstract] [Full Text] [Related]

  • 10. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM, Korn JH, Csuka ME, Medsger TA, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR.
    Arthritis Rheum; 1998 Apr 08; 41(4):670-7. PubMed ID: 9550476
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of systemic scleroderma with ketanserin. Randomized, double-blind 6-months study of 27 cases].
    Cadranel J, Blétry O, Guillevin L, Lacombe C, Fraitag B, Duloroy J, Mouthon JM, Godeau P.
    Ann Med Interne (Paris); 1986 Apr 08; 137(3):260-3. PubMed ID: 3532900
    [Abstract] [Full Text] [Related]

  • 12. Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
    Wigley FM, Wise RA, Malamet R, Scott TE.
    Arthritis Rheum; 1987 Mar 08; 30(3):281-6. PubMed ID: 2952125
    [Abstract] [Full Text] [Related]

  • 13. Nifedipine in the treatment of idiopathic Raynaud's syndrome.
    Sarkozi J, Bookman AA, Mahon W, Ramsay C, Detsky AS, Keystone EC.
    J Rheumatol; 1986 Apr 08; 13(2):331-6. PubMed ID: 3723496
    [Abstract] [Full Text] [Related]

  • 14. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
    Yocum DE, Hodes R, Sundstrom WR, Cleeland CS.
    J Rheumatol; 1985 Feb 08; 12(1):90-3. PubMed ID: 3981523
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
    Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M.
    Rev Rhum Mal Osteoartic; 1982 Apr 08; 49(5):337-43. PubMed ID: 6285445
    [Abstract] [Full Text] [Related]

  • 17. [Calcium antagonists for the treatment of Raynaud's phenomenon].
    Müller-Bühl U, Diehm C, Scheuermann W, Mörl H.
    Dtsch Med Wochenschr; 1983 Nov 25; 108(47):1795-7. PubMed ID: 6357692
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.